BioCentury | Aug 13, 2012
Clinical News

E7016: Phase II started

...30 that it began an open-label, U.S. Phase II trial to evaluate 320 mg oral E7016...
...NYSE:MRK, Whitehouse Station, N.J.) markets Temodar temozolomide. Eisai Co. Ltd. (Tokyo:4523; Osaka:4523), Tokyo, Japan Product: E7016...
Items per page:
1 - 1 of 1